RHUMBLINE ADVISERS - EDGE THERAPEUTICS INC ownership

EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 51 filers reported holding EDGE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of EDGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$21,000
-86.8%
17,552
+3.7%
0.00%
Q4 2017$159,000
-27.1%
16,932
-16.5%
0.00%
Q3 2017$218,000
+6.3%
20,285
+1.6%
0.00%
Q2 2017$205,000
+34.0%
19,960
+19.1%
0.00%
Q1 2017$153,000
-23.5%
16,765
+4.8%
0.00%
-100.0%
Q4 2016$200,000
+28.2%
16,001
+7.0%
0.00%
Q3 2016$156,000
+16.4%
14,950
+12.8%
0.00%
Q2 2016$134,00013,2500.00%
Other shareholders
EDGE THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,344,868$21,362,00010.94%
VHCP Management II, LLC 1,933,582$17,615,0007.21%
ACUTA CAPITAL PARTNERS, LLC 1,351,516$12,312,0002.92%
Opaleye Management Inc. 280,000$2,550,0001.27%
SPHERA FUNDS MANAGEMENT LTD. 150,000$1,367,0000.27%
REGENTATLANTIC CAPITAL LLC 135,000$1,230,0000.11%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 15,401$140,0000.10%
TFS CAPITAL LLC 22,993$209,0000.07%
EAGLE ASSET MANAGEMENT INC 899,968$8,198,0000.05%
Trexquant Investment LP 15,669$143,0000.02%
View complete list of EDGE THERAPEUTICS INC shareholders